{"id":"n_k4b7mwokmvc7kctmnlxa","seq":9421658,"kind":"article","title":"週纖達、猛健樂入列！美FDA要求所有GLP-1藥物加註「罕見視力受損」警示","url":"https://news.cnyes.com/news/id/6655910","summary":"FDA要求所有GLP-1受體促效劑仿單加註罕見眼疾NAION警示。 FDA合併126項試驗、13萬4,253人資料，GLP-1組NAION每10萬人年6.4例，高於對照組3.8例。 諾和諾德稱資料不足證實因果；禮來評估公告內容；花旗估新增警示對整體處方需求影響有限。","published":"2026-11-10T11:10:03Z","seen":"2026-11-10T11:28:49Z","lang":"zh","country":"TW","source":{"id":"kite-news-cnyes-com-887ba2","name":"news.cnyes.com","domain":"news.cnyes.com"},"via":"kite-news-cnyes-com-887ba2","topics":["美股雷達"],"authors":["鉅亨網編譯羅昀玫"],"image":"https://cimg.cnyes.cool/static/rss/default/m/01.jpg","story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.74,"sentiment":"neutral","tone":-0.45,"political":0.06}